Anna Jovanovich
Overview
Explore the profile of Anna Jovanovich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gu J, Chonchol M, Hoffman C, Miyazaki M, Miyazaki-Anzai S, Nowak K, et al.
J Nephrol
. 2025 Jan;
PMID: 39752120
No abstract available.
2.
Jovanovich A, Struemph T, You Z, Wang W, Farmer-Bailey H, Bispham N, et al.
Kidney360
. 2024 May;
5(7):959-966.
PMID: 38781013
No abstract available.
3.
Gitomer B, Wang W, George D, Coleman E, Nowak K, Struemph T, et al.
Contemp Clin Trials
. 2023 Dec;
137:107423.
PMID: 38151173
Background: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the development and continued growth of multiple cysts in the kidneys leading to ultimate loss of kidney function in most...
4.
Jovanovich A, Cai X, Frazier R, Bundy J, He J, Rao P, et al.
J Am Heart Assoc
. 2022 Mar;
11(7):e022891.
PMID: 35322682
Background Deoxycholic acid (DCA) is a secondary bile acid that may promote vascular calcification in experimental settings. Higher DCA levels were associated with prevalent coronary artery calcification (CAC) in a...
5.
Frazier R, Cai X, Lee J, Bundy J, Jovanovich A, Chen J, et al.
Kidney Med
. 2022 Jan;
4(1):100387.
PMID: 35072049
Rationale & Objective: Elevated levels of deoxycholic acid (DCA) are associated with adverse outcomes and may contribute to vascular calcification in patients with chronic kidney disease (CKD). We tested the...
6.
Nowak K, Farmer-Bailey H, Wang W, You Z, Steele C, Cadnapaphornchai M, et al.
Clin J Am Soc Nephrol
. 2021 Dec;
17(2):240-250.
PMID: 34907021
Background And Objectives: Clinical manifestations of autosomal dominant polycystic kidney disease (ADPKD), including evidence of vascular dysfunction, can begin in childhood. Curcumin is a polyphenol found in turmeric that reduces...
7.
Kimber C, Zhang S, Johnson C, West 3rd R, Prokopienko A, Mahnken J, et al.
Kidney360
. 2021 Jul;
1(11):1206-1216.
PMID: 34322673
Background: Recent evidence suggests the systemic accumulation of by-products of gut microbes contributes to cardiovascular morbidity in patients with CKD. Limiting the generation of toxic bacterial by-products by manipulating the...
8.
Nowak K, Jovanovich A, Farmer-Bailey H, Bispham N, Struemph T, Malaczewski M, et al.
Kidney360
. 2020 Dec;
1(6):501-509.
PMID: 33305290
Background: Increased arterial stiffness and vascular endothelial dysfunction are important nontraditional cardiovascular risk factors evident in patients with CKD. Vascular oxidative stress and inflammation may contribute to vascular dysfunction in...
9.
Nowak K, Farmer-Bailey H, Cadnapaphornchai M, You Z, George D, Wang W, et al.
Contemp Clin Trials Commun
. 2020 Dec;
19:100635.
PMID: 33294724
Although often considered to be a disease of adults, complications of autosomal dominant polycystic kidney disease (ADPKD) begin in childhood. While the hallmark of ADPKD is the development and continued...
10.
Jovanovich A, Ginsberg C, You Z, Katz R, Ambrosius W, Berlowitz D, et al.
J Am Geriatr Soc
. 2020 Dec;
69(2):467-473.
PMID: 33289072
Background/objectives: Chronic kidney disease (CKD) is associated with frailty. Fibroblast growth factor 23 (FGF23) is elevated in CKD and associated with frailty among non-CKD older adults and individuals with human...